ClinicalTrials.Veeva

Menu

Registry Study of ID & IDA in Korean Patients With Heart Failure (HFRegistry)

JW Pharmaceutical logo

JW Pharmaceutical

Status

Completed

Conditions

Iron Deficiency Anemia

Study type

Observational

Funder types

Industry

Identifiers

NCT04812873
JWP-FER-401

Details and patient eligibility

About

The prevalence of Iron Deficiency and Iron Deficiency Anemia in Korean HF patient

Full description

Epidemiological study to assess The prevalence of ID (Iron Deficiency) & IDA (Iron Deficiency Anemia) in Korean patients with heart failure

Enrollment

465 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • more than 19 years old

  • Informed Consent Form

  • Hear Failure criteria as belows

    • Heart Failure Sign(more than 1 Sx such as fatigue, dyspnea, ankle swelling)

      • Heart Failure Symptom(more than 1 among Jugular venous pressure (JVP) elevation, pulmonary crackle, peripheral edema) ③ Lung congestion or edema at chest X-ray ④ Objective findings of structural or functional cardiac abnormality(more than abnormality level of BNP or NT-proBNP, abnormality of echocardiography )

Exclusion criteria

  • Not applicable

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems